Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ

Table 4 Multivariate linear regression for predictive factors on PCS, MCS, and CLDQ (n = 108)**

Variables entered	PCS			MCS			CLDQ
	β(SE)	P	b	β(SE)	P	b	β(SE)	P	b
Treatment duration (<8 weeks as reference)
9–16 weeks	-9.38(2.69)	0.00	-0.33	0.66(2.81)	0.82	0.02	-0.32(0.22)	0.16	-0.15
>17 weeks	-3.83(2.88)	0.19	-0.13	1.56(3.00)	0.60	0.05	0.09(0.24)	0.72	0.04
Monthly income (≤NT$10,000 as reference)
>NT$30,000	8.47(3.54)	0.02	0.33	8.79(3.69)	0.02	0.35	0.68(0.29)	0.02	0.34
NT$10,001 ~ 30000	5.69(3.39)	0.10	0.19	7.13(3.54)	0.05	0.24	0.37(0.28)	0.19	0.16
Gender (female as reference)	4.39(2.44)	0.08	0.18	4.80(2.54)	0.06	0.20	0.43(0.20)	0.04	0.23
R²	0.28			0.16			0.16

β = regression coefficient, b = standardized regression coefficient, SE = standard error.
**Adjusted for age, gender, marital status, education, current employment, and serum ALT level.